🔗 Share this article Patients Stopping Slimming Jabs Gain Back Pounds Far More Rapidly Compared to Dieters Weight management involves ongoing approaches. Fresh analysis indicates that people who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens. Research printed in a major medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation. "People using these drugs should be cognizant of the potential of rapid weight regain when the medication concludes," stated expert Dr. Susan Jebb. This pace of regain suggests a reversion to original mass in about 18 months. Weighing Treatments The study, which examined dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with older methods. Researchers note that individuals who shed pounds through dieting generally see a more gradual creep back—approximately 0.1 kg a month—once they finish. Understanding the Rapid Rebound Experts believe the mechanism of the drugs is key to understanding the accelerated regain. The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Artificially providing GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication means appetite is unsuppressed, making excessive eating far more likely." An Ongoing Issue? Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes. Professionals say that, considering the high risk of relapse, the therapy is often life-long. This perspective is echoed by drug manufacturers, who say that the results "underscore the chronic character of excess weight," akin to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a intense return of cravings. "It felt as if a switch flipping and I was suddenly starving," recalled one woman. The struggle is worsened if individuals have not developed sustainable lifestyle or habit changes during therapy. Growing Interest Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow. Adoption is greater among females compared to males. The middle-aged age group shows the highest usage rates. Many access the medications through private prescriptions rather than public health services. Ultimately, experts stress that while GLP-1 drugs are powerful tools for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle management.
Weight management involves ongoing approaches. Fresh analysis indicates that people who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens. Research printed in a major medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation. "People using these drugs should be cognizant of the potential of rapid weight regain when the medication concludes," stated expert Dr. Susan Jebb. This pace of regain suggests a reversion to original mass in about 18 months. Weighing Treatments The study, which examined dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with older methods. Researchers note that individuals who shed pounds through dieting generally see a more gradual creep back—approximately 0.1 kg a month—once they finish. Understanding the Rapid Rebound Experts believe the mechanism of the drugs is key to understanding the accelerated regain. The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Artificially providing GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication means appetite is unsuppressed, making excessive eating far more likely." An Ongoing Issue? Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes. Professionals say that, considering the high risk of relapse, the therapy is often life-long. This perspective is echoed by drug manufacturers, who say that the results "underscore the chronic character of excess weight," akin to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a intense return of cravings. "It felt as if a switch flipping and I was suddenly starving," recalled one woman. The struggle is worsened if individuals have not developed sustainable lifestyle or habit changes during therapy. Growing Interest Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow. Adoption is greater among females compared to males. The middle-aged age group shows the highest usage rates. Many access the medications through private prescriptions rather than public health services. Ultimately, experts stress that while GLP-1 drugs are powerful tools for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle management.